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Abstract – Microorganisms play essential roles in the manufacture and ripening of cheese, largely
contributing to the development of organoleptic properties by their metabolism and varied enzy-
matic activities, and to microbiological safety through barrier eﬀects of complex microﬂora and
production of several low-molecular-weight antimicrobial compounds. Although extensive research
has been done on bacteriocins of cheese bacteria for controlling pathogens in cheese, until now
only few applications have emerged. The control of spoilage yeasts and moulds has been tradi-
tionally done by chemical additives, but the application of new antifungal protective cultures is
very promising, especially for the cheese industry. It has also been recently shown that naturally
established cheese microﬂora can eﬃciently prevent the growth of pathogenic or spoilage microor-
ganisms. Cheese is also a very suitable but underused carrier for the delivery of probiotic bacteria,
conferring health beneﬁts on the host, with speciﬁc advantages compared with fermented milks and
yoghurts such as high cell viability. This review addresses the latest developments in applications of
protective cultures (with bacteriocin and antifungal activities) or microﬂora with barrier eﬀects, and
probiotic cultures for the production of high quality, safe and “healthy” cheese, as well as emphasiz-
ing some of the underlying challenges and possible solutions. Furthermore, new safety criteria for
food cultures relating to the presence and transferability of antibiotic resistance genes are discussed.
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摘要 –具有保护和移哨功能的干酪发酵剂的研究截展。微生物在干酪的制造和成熟中起
着关键性的作用,微生物的代谢产物和酶的活性赋予干酪的感官品质,复杂微生物菌群的阻
隔效应和产生的一些小分子抗菌化合物是干酪微生物安全的保障。尽管关于细菌素用于控
制干酪中病原菌的报道很多,但到目前为止该技术的实际应用还是非常有限。控制干酪中腐
败酵母菌和霉菌的传统方法还是添加化学防腐剂,因此,有必要开发一些具有抗真菌作用,特
别是适用于干酪生产的保护性发酵剂。最新的研究结果表明,天然干酪中形成的微生物菌群
可以有效地防止一些病原微生物和腐败微生物的生长。与富含高活力细菌的发酵乳和酸乳
相比,干酪还是一种益生菌很好的载体和传递者,但没引起足够重视,它有利于人体吸收其中
有益健康的成分。本文论述了能产生细菌素和抗真菌的保护性发酵剂或具有阻隔效应的微
生物菌群;能够生产高质量、安全和有益健康干酪的益生菌发酵剂在干酪生产中应用的最新
进展以及在工业化生产中存在的问题。此外,本文还讨论了食品发酵剂中抗生素抗性基因存
在和转移的安全标准。
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Résumé – Avancées des connaissances sur les cultures à activité protectrice et probiotique
pour des applications fromagères. Les microorganismes jouent un rôle essentiel dans la prépara-
tion et l’aﬃnage des fromages en contribuant de façon importante au développement des propriétés
organoleptiques par leur métabolisme et la grande variété de leurs activités enzymatiques, et à la
sécurité microbiologique du produit à travers les eﬀets barrières des microﬂores complexes et/ou
la production de composés antimicrobiens de faibles poids moléculaires. De nombreux travaux de
recherche ont été réalisés sur les bactériocines produites par des bactéries isolées de fromages pour
contrôler le développement de microorganismes pathogènes. Cependant, très peu d’applications
sont issues de ces travaux. Le développement des levures et moisissures nuisibles à la qualité des
fromages est traditionnellement contrôlé par des additifs chimiques mais leur remplacement par
des cultures protectrices antifongiques semble prometteur. Des études ont récemment rapporté le
potentiel de ﬂores naturellement établies sur des fromages pour le contrôle de ﬂores pathogènes et
de dégradation. Les fromages constituent également un vecteur adéquat, mais sous-exploité, pour
les bactéries probiotiques conférant un bénéﬁce santé pour le consommateur. Les fromages per-
mettent notamment de maintenir un meilleur taux de viabilité de ces bactéries comparativement à
d’autres matrices telles que les yoghourts et laits fermentés. Cette revue fait le point sur les derniers
développements sur les cultures protectrices (productrices de bactériocines, à activité antifongique
ou à eﬀets barrières) et probiotiques pour la production de fromages de haute qualité organolep-
tique et microbiologique, et ayant un eﬀet bénéﬁque sur la santé du consommateur. Les contraintes
technologiques associées à l’utilisation de ces cultures sont également abordées et des solutions
proposées. De nouveaux critères pour la sélection de cultures microbiennes destinées à un usage
alimentaire et portant sur la présence et le transfert de gènes de résistance aux antibiotiques sont
également soulignés.
fromage / bactériocine / antifongique / probiotique / antibiorésistance / technologie
1. INTRODUCTION
The many activities of starter and ripen-
ing cultures are central for quality and mi-
crobiological safety of cheese. Lactic acid
bacteria (LAB) are currently almost always
added to cheese milk to produce lactic
acid from lactose and contribute to bio-
chemical changes during ripening and de-
velop the characteristics of cheese. Sev-
eral beneﬁcial health eﬀects related to the
consumption of some LAB (called probi-
otic culture) have also been demonstrated.
This potential has been largely exploited in
functional dairy foods, mainly yoghurt and
fermented milks. Although numerous stud-
ies have been devoted to incorporation of
probiotic cultures into cheese, few probi-
otic cheeses are commercially produced.
On the other hand, a large variety
of other microorganisms originating from
many sources (milk, equipment, ripening
rooms, human) and growing in the mass
and on the surface of cheese also partic-
ipate in cheese and greatly contribute to
the characteristics and diversity of cheese.
This microbiota, which is relatively diﬃ-
cult to control, may also be contaminated
by spoilage and/or pathogenic microorgan-
isms and thereby, be a source of undesired
contaminants for cheese. In contrast, cul-
tures isolated from cheese or milk have a
protective eﬀect against the development
of contaminants. The implementation by
the cheese industry of such protective cul-
tures could contribute with other classical
measures (e.g. milk pasteurization, use of
deﬁned starter) to control the development
of undesired microorganisms and further
improve quality and safety of cheese.
In this review, the latest developments in
the application of protective and probiotic
cultures for the production of high qual-
ity, safe and “healthy” cheese have been
reviewed, with underlying challenges and
possible solutions.
2. PROTECTIVE CULTURES
IN CHEESE
The implementation in the nineties of
the Hazard Analysis Critical Control Point
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plan and other preventive measures in the
cheese industry have greatly contributed
to the reduction of the incidence of food-
borne diseases related to cheese consump-
tion. For example, during the period 1993–
1996, the number of dairy products highly
contaminated by Listeria monocytogenes
(i.e.  100 cfu·g−1) in France decreased by
41% [64]. However, a recent study on re-
tail cheeses in the UK has shown that 5 and
4% of cheeses made from unpasteurized
(including thermized milk) and pasteurized
milk, respectively, were of unsatisfactory
or borderline quality according to EC rec-
ommendations 2004/24 and 2005/175 for
the presence of Salmonella, Staphylococ-
cus aureus, Escherichia coli and L. mono-
cytogenes [82]. A cheese with microbi-
ological borderline quality can also be
rapidly considered unsatisfactory if stored
under inappropriate conditions at home.
Yeasts and moulds are also common,
sometimes major, spoilage organisms of
food products, especially fermented milk
products and cheeses. These organisms,
which cause severe economic losses and
signiﬁcantly reduce the shelf life of prod-
ucts, may constitute a health hazard due to
the production of mycotoxins [47,48,129].
Therefore, there is a real need to enhance
the control of microbiological safety of
cheese from milk to the consumer, and
this can be achieved by microbial cultures
with antimicrobial features and protective
eﬀects in cheese.
2.1. Bacteriocins and
bacteriocinogenic strains
In the last two decades, several studies
have demonstrated the potential of bacteri-
ocins to control growth of pathogenic mi-
croorganisms in food products [26]. Bac-
teriocins are peptides with antimicrobial
activity produced by a wide diversity of
bacteria. To date, most of the identiﬁed
Gram-positive bacteriocins are produced
by LAB, among which there are gener-
ally recognized as safe (GRAS) organisms
used for milk fermentations [66]. More-
over, bacteriocins can be rapidly degraded
by proteases in the gastrointestinal tract
and therefore they should not interfere with
human gut microbiota [12]. Finally, bac-
teriocins produced in situ by food-grade
bacteria do not have to be indicated on
the product label. Most research on bac-
teriocins in cheese have targeted the con-
trol of L. monocytogenes, or other listeria
species used as model for this pathogen,
and clostridia spores responsible for late
blowing defects in semi-hard and hard
cheeses.
2.1.1. The “classical” bacteriocins
for cheese
Nisin, a class I bacteriocin (< 5kDa
peptides containing unusual lanthionine
amino acids) produced by lactococci is
the best documented bacteriocin of LAB
and remains a model for the develop-
ment of other bacteriocins. To date, nisin,
as a food additive, is the only bacteri-
ocin that has received regulatory approval
from the US Food and Drug Administra-
tion and European Union (listed as E234)
and can be labeled as a “natural preserva-
tive”. Its broad activity spectrum includes
listeria, enterococci, staphylococci, strep-
tococci, clostridia, Campylobacter jejuni,
Helicobacter pylori and antibiotic-resistant
strains of Neisseria gonorrhoeae [94,128].
However, the stability of nisin is highly
dependent on environmental conditions,
in particular pH, and this limits its use
to acidic foods [116]. In addition, nisin
can be degraded by proteolytic enzymes
in cheese, leading to a signiﬁcant activ-
ity decrease during ripening. For exam-
ple, Benech et al. [8] showed that only
12% of the initial activity produced by
a nisinogenic starter remained in Ched-
dar cheese after 6 months of ripening.
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However, encapsulation of puriﬁed nisin
into liposomes allowed the retention of
90% of initial nisin activity and thereby,
resulted in an improved control of Listeria
innocua populations in artiﬁcially contam-
inated cheese during ripening [8]. How-
ever, until now only few applications of
nisin in the cheese industry have emerged,
as summarized in recent reviews [21, 55,
130].
In contrast to nisin, lacticin 3147, a two-
component broad-spectrum antimicrobial
peptide produced by Lactococcus lactis
subsp. lactis DPC3147 showed high sta-
bility over a wide range of pH [117]. No
decrease in in situ produced lacticin activ-
ity was detected in Cheddar cheese over
6 months of ripening [119]. However, the
application of the lacticin 3147 producer
strain on surfaces of smear-ripened cheese
as a pretreatment for controlling L. mono-
cytogenes contamination was not eﬀec-
tive [102].
Pediocin AcH (also known as pediocin
PA-1 or SJ-1) is another broad-spectrum
anti-listerial bacteriocin that belongs to
class II (non-modiﬁed heat-stable peptides
< 10 kDa). It is produced mainly by
Pediococcus acidilactici [39], a minor pop-
ulation in many cheeses. However, Lac-
tobacillus plantarum WHE (commercially
available as ALC 01, anti-listerial culture,
Danisco, Germany) isolated from Mun-
ster cheese was also shown to produce pe-
diocin [40]. Production of pediocin AcH
by P. acidilactici H was considerably re-
duced when ﬁnal medium pH exceeded
5.0. In contrast, bacteriocin production by
Lb. plantarum WHE 92 was not aﬀected
for pH values up to 6.0, which is a clear ad-
vantage for cheese application [40]. Spray-
ing a cell suspension of Lb. plantarum
WHE 92 on surfaces of Munster cheese at
the beginning of ripening inhibited growth
of L. monocytogenes for 21 days [41].
However, Loessner et al. [83] stressed the
risk of development of resistance when pe-
diocin AcH or the producer strain is used
to control L. monocytogenes on cheese sur-
faces.
2.1.2. Newly developed bacteriocins
for cheese applications
In recent years, several other bacteri-
ocins with potential use in cheese have
been reported. Streptococcus and Entero-
coccus, two genera with particular rele-
vance in cheese manufacture, also produce
a large diversity of bacteriocins [99].
Thermophilin, produced by some
strains of Streptococcus thermophilus, is a
class II bacteriocin with inhibitory activity
against Streptococcus, Enterococcus,
Lactococcus, Bacillus and Listeria [51].
Streptococcus macedonicus is a relatively
new species ﬁrst isolated from Kasseri, a
Greek hard-cooked cheese [137]. Mace-
docin, produced by Str. macedonicus
ACA-DC 198, belongs to the lantibi-
otic bacteriocins (Class I) and inhibits
several LAB as well as Clostridium
tyrobutyricum [59]. C. tyrobutyricum is
responsible for large defects in semi-hard
and hard cheeses, such as Swiss-type or
Gouda, due to high production of butyric
and acetic acid, CO2 and H2 from fer-
mentation of lactate, leading to signiﬁcant
ﬂavor defects and late cheese blowing [6].
Germination of Clostridia spores can be
inhibited by additives such as nitrate,
lysozyme or nisin, but their uses can be
restricted by local regulations [6]. There-
fore, the use of the macedocin producer
strain as adjunct culture could be a rele-
vant alternative for controlling Clostridia
development. Unlike nisinogenic lacto-
cocci, Str. macedonicus is not inhibited
by the cooking step of the manufacture
process, and macedocin is stable over a
wide range of pH and upon prolonged
fermentation [138]. Recently, Anastasiou
et al. [4] evaluated the performance of Str.
macedonicus ACA-DC 198 used as sole
starter or adjunct culture in the production
of Kasseri cheese from pasteurized milk.
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After some changes in the process (i.e.
time to reach a pH of 5.2 in the drained
curd and temperature/duration of ripen-
ing), no major eﬀects were observed
on microbiological, physicochemical or
sensorial characteristics of cheeses made
with Str. thermophilus ACA-DC 198 alone
or mixed with a commercial starter culture
compared with control cheese with only
commercial starter [4]. Furthermore, Str.
macedonicus ACA-DC 198 was used as
starter or adjunct culture and macedocin
was detected until the end of cheese ripen-
ing (90 days) [4]. However, the eﬃciency
of macedocin inhibiting Clostridia in situ
has not yet been tested in cheese.
Enterococci are used as starter or non-
starter lactic acid bacteria (NSLAB) in
many traditional Mediterranean cheeses,
where they greatly contribute to the de-
velopment of organoleptic properties dur-
ing ripening through proteolysis, lipoly-
sis and breakdown of citrate into aroma
compounds [60]. Although some mem-
bers of the Enterococcus genus are also
pathogenic and involved in the transfer of
antibiotic resistance and/or virulence fac-
tors, others are considered safe and even
used as probiotics [52]. Many enterococci
can produce bacteriocins belonging exclu-
sively to the heat-stable, non-lantibiotic
class II, with the exception of cytolysin,
a two-peptide lantibiotic (Class I) associ-
ated with virulence of some Enterococcus
faecalis strains due to its hemolytic activ-
ity [99]. Nuñez et al. [101] have inves-
tigated the inhibition of two L. monocy-
togenes strains by enterocin 4, produced
in situ by E. faecalis INIA 4 during the
manufacture and ripening of Manchego
cheese. The population of L. monocyto-
genes Ohio, initially at 105 cells per mL
in raw milk, decreased to less than 102
cells per gram of curd 8 h after the start
of manufacture when E. faecalis INIA 4
was used as sole starter or adjunct culture.
From ripening days 2 to 60, L. monocyto-
genes Ohio was only recovered in cheeses
manufactured with E. faecalis INIA 4, with
or without commercial culture, after an en-
richment procedure of 25 g of cheese sam-
ple [101]. In contrast, the population of
L. monocytogenes Ohio in control cheeses
remained stable at 3.9 × 104 cells per gram.
However, E. faecalis INIA 4 as sole starter
failed to inhibit growth of L. monocyto-
genes Scott A under the same conditions.
Bactericidal synergism between heat
pretreatment (65 ◦C, 5 min) and the en-
terocin AS-48 produced by E. faecalis
A-48-32 was shown on inhibition of S.
aureus in skimmed milk [97]. Compared
with acidiﬁed skimmed milk a lower eﬃ-
cacy was measured in cheese when E. fae-
calis A-48-32 and Enterococcus faecium
UJA32-81, both enterocin AS-38 produc-
ers, were used as starter or adjunct cul-
ture, to inhibit growth of S. aureus [97].
This result was tentatively explained by
a lower production of enterocin AS-38 in
cheese and/or diﬀerence in bacteriocin ac-
tivity due to cheese matrix and temper-
ature conditions (i.e. 28 ◦C for acidiﬁed
skimmed milk and 4 ◦C for cheese ripen-
ing) [97]. Another important factor, pH,
may have also inﬂuenced bacteriocin activ-
ity but was not reported in the study.
To conclude this section, the relevance
of bacteriocinogenic strains as “protective
cultures” varies among the diﬀerent stud-
ies. Indeed, the eﬃcacy of a bacteriocin
producer or bacteriocin with high poten-
tial in simple experimental set-up condi-
tions (e.g. synthetic medium, controlled
temperature and pH) to control growth
of pathogens can be very diﬀerent when
used in cheese due to several factors: com-
petition with the starter culture, complex
interactions between the bacteriocin and
cheese matrix, presence of inhibitors (e.g.
proteases), and/or non-optimal conditions
(e.g. pH, temperature) for growth and bac-
teriocin synthesis. In addition, cheese com-
position may also greatly diﬀer from core
to surface in terms of microﬂora diversity,
environmental conditions, particularly salt
426 F. Grattepanche et al.
and water contents, and pH. Thus, bac-
teriocin production and eﬃciency can
greatly vary within cheese. Bacteriocino-
genic strains used as starter or adjunct cul-
ture must also show good growth in milk
and/or cheese since bacteriocin produc-
tion is usually directly correlated with ﬁnal
biomass.
Safety considerations using bacteriocins
or their producer strains is an important is-
sue since cross-resistances between diﬀer-
ent classes of bacteriocins and/or antibi-
otics have already been reported [74, 98].
Moreover, some bacteriocinogenic strains
also belong to genera or species (e.g. ente-
rococci) which include pathogenic strains.
Applications of such strains at high levels
in cheese should be carefully assessed for
the risk to beneﬁt ratio. Solutions proposed
to overcome these major drawbacks will be
discussed below (Sect. 5). Finally, the bal-
ance of the microﬂora of cheese, a key pri-
ority for proper ripening and ﬁnal quality,
can be aﬀected by bacteriocins or bacteri-
ocinogenic strains; this problem should be
carefully assessed for each cheese type as
discussed below.
2.1.3. Impact of bacteriocins and
bacteriocinogenic strains on
cheese ripening
The microﬂora of cheese, through its
diverse metabolic activities and release of
enzymes, plays an important role in the de-
velopment of typical texture, ﬂavor and ap-
pearance of ripened cheeses. Only GRAS
bacteria for speciﬁc food uses can be incor-
porated in dairy products. For in situ bac-
teriocin production in cheese, the strains
must also be able to grow at high lev-
els and/or be metabolically active in the
cheese environment. Therefore, only bac-
teriocins from LAB, generally isolated
from cheese, have been used. Bacteriocins,
most of them with a narrow, and some like
nisin and pediocin with a broader activ-
ity spectrum, are active on bacteria closely
related to the producer strain or conﬁned to
the same ecological niche [75]. Thus, the
presence of bacteriocin, produced in situ or
added, can disrupt the natural balance and
dynamics of the cheese microﬂora, includ-
ing starter cultures.
The acidifying capacity of nisin-
tolerant lactococci was not signiﬁcantly
aﬀected by the presence of a nisinogenic
strain, whereas a signiﬁcant decrease was
observed for a commercial culture and
nisin-sensitive lactococci during growth
in milk [8]. Benech et al. [7] studied the
textural, physicochemical and sensory
attributes of Cheddar cheese made with
a mixed culture containing Lactococcus
lactis subsp. lactis biovar. diacetylactis
UL719 and two nisin-tolerant lactococci.
After 6 months of ripening, rheological
properties were not signiﬁcantly diﬀerent
while proteolysis, lipolysis and formation
of hydrophilic and hydrophobic pep-
tides increased in cheese containing the
nisin Z producer compared with control
cheese [7]. Enzymatic capabilities of Lc.
diacetylactis UL719 cells or autolysis
of a nisin-sensitive subpopulation of the
starter may be responsible for proteolysis
in cheese containing the bacteriocino-
genic strain [7]. In this study, the two
nisin-tolerant lactococci were also selected
for their high acidifying capacity in milk.
However, for cheeses produced using these
two strains, in combination or not with
Lc. diacetylactis UL719, a bitter oﬀ-ﬂavor
and an acidic taste were observed [7],
probably due to a low amino-peptidasic
activity of these strains compared with
commercial starter cultures. Nevertheless,
cheese bitterness could be corrected and
ﬂavor improved by incorporating a high
proteolytic strain, Lactobacillus casei
subsp. casei L2A, in the mixed lactococci
starter containing the nisin Z producer [7].
Similar results were recently reported for
Hispanico cheese manufactured using a
lacticin 481 producing strain, Lc. lactis
INIA 639, a non-bacteriocinogenic strain,
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Lc. lactis INIA 437, and Lactobacillus hel-
veticus with high amino-peptidase activity
and sensitive to lacticin 481 [57]. Analysis
of volatile compounds also showed an
enhanced production of 2-methylpropanal,
2-methylbutanal, ethanol, 1-propanol,
ethyl acetate, ethyl butanoate and ethyl
hexanoate in lacticin cheeses, which
reached higher scores for aroma quality
and intensity compared with control
cheese made with both starter and adjunct
culture [56].
Bacteriocins have been shown to induce
lysis of sensitive starter cultures, leading
to a fast release of intracellular enzymes
which enhance cheese ﬂavor develop-
ment [86,88,95]. Bacteriocins may also fa-
cilitate diﬀusion in the cells of molecules,
such as amino acids, through membrane
permeabilization. The increased amino-
acid pool may lead to an increased rate
of transamination and formation of α-keto
acids which can be further degraded enzy-
matically into ﬂavor compounds [87].
2.2. Protective cultures producing
non-proteinaceous low-
molecular-weight antimicrobial
compounds
Recently, antifungal cultures have
gained importance for cheese applications
although limited work has been done in
this ﬁeld. The antifungal properties of LAB
have been recently reviewed by Schnürer
and Magnusson [125]. The assessment of
cheese spoilage by yeasts and moulds is
complicated because fungal activity during
ripening can be either needed or detrimen-
tal to product quality, depending on the
type of cheese and microorganisms [48].
Spoilage of cheese due to fungal growth
is caused by the production of volatile
compounds, leading to oﬀ-ﬂavors, and
also mycotoxin accumulation, which may
promote allergies [47, 129]. Penicillium
spp. and Aspergillus spp. are important
spoilage moulds in preservative-free hard,
semi-hard and semi-soft cheeses, whereas
Candida spp., Kluyveromyces marxianus
and Pichia spp. are main contaminants in
unripened soft cheeses [47, 48].
The control of spoilage yeasts and
moulds is traditionally done by chemical
additives such as sorbic and benzoic acids,
which both have a broad activity spectrum.
Furthermore, the antibiotic natamycin pro-
duced by Streptomyces natalensis is eﬀec-
tive against fungi and is used as a common
preservative on hard cheese surfaces [22,
34]. In contrast, consumers are increas-
ingly demanding high quality, safe and
mildly processed foods with long shelf life
and low or no addition of chemical preser-
vatives. Furthermore, fungi also showed
an increased resistance to antibiotics and
chemical preservatives such as sorbic and
benzoic acids [18]. Thus, the application
of antifungal protective food cultures has a
high potential, especially in dairy products
such as cheeses or fermented milks.
So far, only a few antifungal pro-
tective cultures are commercialized and
their applications are still emerging, es-
pecially for dairy products but also for
other foods and feeds (Tab. I). Two pro-
tective cultures are currently marketed by
Danisco (Danisco, Copenhagen, Denmark)
as the HOLDBACTM range, combining
two strains of Propionibacterium freuden-
reichii subsp. shermanii JS and Lactobacil-
lus rhamnosus LC705 [133] or Lactobacil-
lus paracasei SM20 [91,92]. Both cultures
have been successfully tested in yoghurt
and on the surface of hard cheese to pre-
vent spoilage by yeasts and moulds [91].
In contrast to antibacterial peptides,
only little is known about antifungal
mechanisms. So far, research has mainly
been directed towards identifying dif-
ferent antifungal metabolites produced
in simple in vitro fermentations, but
detected antifungal metabolites were not
solely responsible for antifungal features
of a particular strain or culture. Due
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to complex and synergistic interactions
between diﬀerent low-molecular-weight
compounds and likely cell-to-cell interac-
tions, the overall mechanisms are diﬃcult
to elucidate [125]. Recently, we identiﬁed
the production of several antimicrobials,
including 2-pyrrolidone-5-carboxylic acid,
3-phenyllactic acid, hydroxyphenyl-
lactic acid, and succinic acid besides
propionic and acetic acids, during fer-
mentations of Lb. paracasei SM20
and Propionibacterium jensenii SM11
in whey-based medium (unpublished
data). Similarly, Lb. rhamnosus LC705
was shown to produce 2-pyrrolidone-
5-carboxylic acid [140]. Furthermore,
mixtures including acetic, caproic, formic,
propionic, butyric, n-valeric, and benzoic
acids, as well as 3-hydroxy fatty acids,
proteinaceous compounds and cyclic
dipeptides were described as antifungal
compounds of LAB [29,84,100,127,132].
One common characteristic was that all
these compounds had to be present at low
concentrations in contrast to high mini-
mal inhibitory concentrations for fungi,
conﬁrming the complexity of antifungal
mechanisms [132, 140].
The application of antifungal protective
cultures is very promising, especially for
the cheese industry. Several strains have
been recently developed for cheese appli-
cations but further research is required to
elucidate their mechanisms, reduce costs
and for implementation by the industry.
High eﬀectiveness of protective cultures
is often related to high inoculation levels,
which can aﬀect food quality and increase
costs compared with traditional chemical
preservation [91]. Clearly, careful opti-
mization of antifungal systems and their
applications are required.
2.3. Barrier eﬀects of complex cheese
microbiota
Cheese surface consortia are known to
be complex ecosystems, exhibiting high
species and strain diversity of bacteria and
eukaryotes. Recently developed molecu-
lar tools such as pulsed ﬁeld gel elec-
trophoresis (PFGE), which is a culture-
dependent method, temporal temperature
gel electrophoresis (TTGE), denaturing
gradient gel electrophoresis (DGGE), sin-
gle strand conformation polymorphism
(SSCP), and terminal restriction fragment
length polymorphism- (TRFLP-) or length
heterogeneity- (LH-) PCR have been suc-
cessfully used to explore diversity and dy-
namics of cheese microﬂora [30, 35, 49,
80,103,113,114]. Throughout cheese man-
ufacturing and ripening, the development
of the microﬂora is inﬂuenced by negative
interactions between the diﬀerent micro-
bial populations, such as competition for
nutrients, as well as stimulating interac-
tions, such as pH increase and production
of growth factors [96]. Both bacterial and
eukaryotic populations evolve, with some
species disappearing and others becoming
predominant.
Naturally established cheese microﬂora
were found to be more or less permissive
for the growth of pathogenic or spoilage
microorganisms [13, 85, 93, 124]. The in-
hibitory activity was related to biodiversity
and/or dynamics of the microﬂora because
no antimicrobial activity was detected with
pure cultures of the isolated strains.
Diﬀerent hypotheses can be formu-
lated to explain the antimicrobial activ-
ity of complex consortia. Certain factors
associated with their metabolism (e.g. or-
ganic acids and H2O2 production, nutrient
depletion) together with cheese manufac-
ture parameters (e.g. temperature, salt con-
centration) might exert synergic actions,
inhibiting pathogenic or spoilage microor-
ganisms. It is also well known that bacte-
riocin synthesis can be regulated by quo-
rum sensing systems [62]. In this case,
signaling molecules produced by one pop-
ulation of cheese consortia are believed to
trigger bacteriocin production by another
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population, thus explaining the absence of
anti-microbial activity of pure cultures.
The selection of complex surface mi-
croﬂora to control the growth of spoilage
and pathogenic microorganisms in cheese
appears to be a promising avenue because
no modiﬁcation of process is required.
However, further studies are needed to un-
derstand better mechanisms contributing
to antimicrobial activity. The controlled
propagation-production of such microﬂora
for large-scale applications is a technolog-
ical challenge, as presented below.
3. PROBIOTIC CULTURES
IN CHEESE
Probiotics are deﬁned by the
FAO/WHO [45] as “live microorgan-
isms which when administered in adequate
amounts confer a health beneﬁt on the
host”. The beneﬁcial eﬀects in treatment
and prevention of various diseases or gut
disorders such as inﬂammatory bowel
disease or lactose intolerance are greatly
debated in the literature [106]. Probiotic
microorganisms include several genera of
bacteria and yeasts [68], and among those,
strains of enterococci, lactobacilli and
propionibacteria are important for manu-
facturing some cheeses [52, 90, 108], and
well adapted to the cheese environment.
On the other hand, biﬁdobacteria and
Lactobacillus acidophilus are most used
in functional dairy foods containing probi-
otics, especially milk, yoghurt, ice cream
and desserts [20]. However, conditions
encountered in these products are very dif-
ferent from those of their natural habitat,
the gastrointestinal tract of humans and an-
imals. Thus, product composition can have
deleterious eﬀects on their viability, which
is one of the most important prerequisites
for beneﬁcial health eﬀects [106]. Due to
its limited acidity, low oxygen level, high
lipid content and low storage temperature,
cheese is a suitable carrier for delivering
live probiotic bacteria [15].
3.1. Characteristics of probiotic
biﬁdobacteria and lactobacilli
related to their viability in
cheeses
Viability of probiotics is a key param-
eter for eﬃcacy of probiotic products. Al-
though the amount of cells required to pro-
duce beneﬁcial health eﬀects is not known,
some authors have suggested a daily in-
take of at least 108–109 viable cells as the
minimum intake to provide a therapeutic
eﬀect [118]. A minimum level of 106 cfu
of probiotic bacteria per gram of product
at the time of consumption is generally
accepted and selected to provide bacterial
concentrations that are technologically at-
tainable and cost-eﬀective [79, 123]. Ac-
cording to this criterion, most cheeses
seem to be suitable carriers for probiotic
bacteria, as indicated by the high stabil-
ity of viable cell counts reported for many
cheeses during storage (Tab. II).
Probiotic biﬁdobacteria and lactobacilli
of gut origin are generally classiﬁed
as strictly anaerobic or microaerophilic
but their resistance to oxygen is strain-
and species-dependent [134]. They usu-
ally show poor resistance under prolonged
acidic conditions, with lactobacilli be-
ing less aﬀected than biﬁdobacteria [20].
These characteristics explain the higher
survival of probiotic cultures in cheese
compared with other dairy products, in par-
ticular yoghurts and fermented milks [72,
126]. Indeed, yoghurt has an initial pH
of about 4.1–4.4 that decreases to 3.8–
4.2 during refrigerated storage due to lac-
tic acid production by Lactobacillus del-
brueckii subsp. bulgaricus. On the other
hand, the curd of soft cheeses has a
pH below 5.0 after production (about
4.5 for Camembert cheese) but it in-
creases rapidly during ripening. In 35-day
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ripened Camembert cheese, pH in the
core and the rind reached high values,
around 6.8 and 7.5, respectively [2]. The
pH of hard and semi-hard cheeses, gener-
ally above 5.0 after production, remained
relatively constant throughout the ripen-
ing period [23]. Furthermore, the cheese
core can be considered as an anaerobic
environment with very low redox poten-
tial (Eh) of about –250 mV [9]. The re-
dox potential of Camembert cheese dur-
ing ripening has been shown to increase
from +330 to +360 mV on the surface
and decrease from –300 to –360 mV in
the core [2]. In contrast, Eh is positive in
yoghurt and increases with storage time
above +120 mV [32,33]. Other parameters
have been reported to inﬂuence probiotic
viability in cheese, such as temperature and
duration of ripening, presence of NSLAB
with antagonistic activities, milk pasteur-
ization and salt content [63, 104, 105, 112,
141].
Several biﬁdobacteria strains have been
successfully incorporated into cheeses
with no major changes in the process
(Tab. II). This is diﬀerent from yoghurt,
where the incorporation of biﬁdobacte-
ria is generally limited to Biﬁdobacterium
animalis, a bacteria isolated from animals,
due to its high acid and oxygen tolerance
compared with human biﬁdobacteria [20,
72]. Because the health beneﬁts of animal
biﬁdobacteria have not been researched to
the same extent as human species [72],
cheese is a promising carrier for enlarging
the range of biﬁdobacteria added to func-
tional foods. Furthermore, cheese is also
a suitable protective carrier against harsh
stomach conditions. Vinderola et al. [139]
have reported high survival for Biﬁdobac-
terium biﬁdum, Lb. acidophilus and Lb.
casei added to Argentinian Fresco cheese
and subjected to a pH of 3.0 for 3 h at
37 ◦C. In an in vitro test, Cheddar cheese
containing a probiotic strain of E. faecium
gave greater protection to the strain ex-
posed to porcine gastric juice at pH 2.0
than yoghurt [58]. Cellular response of
P. freudenreichii to technological stresses
during Swiss-type cheese manufacture has
also been reported to increase resistance of
cells to acidic conditions [71].
However, although cheese is likely one
of the best carriers for probiotics, the
addition of high numbers of viable and
metabolically active cells can aﬀect prod-
uct quality, especially organoleptic proper-
ties, as discussed below.
3.2. Eﬀects of probiotic
biﬁdobacteria and lactobacilli
on cheese quality
The gross chemical composition of
cheese (i.e. salt, protein, fat and moisture)
and pH are generally not inﬂuenced by
added probiotic bacteria [10, 11, 19, 28, 31,
37, 61, 104, 105, 141]. However, in Ched-
dar cheese containing Biﬁdobacterium lac-
tis Bb-12, Mc Brearty et al. [89] measured
a higher moisture level of 40%, exceed-
ing the legal limit, compared with con-
trol cheese containing about 38% moisture.
This eﬀect, leading to low body/texture
scores in sensory analysis, was explained
by a rapid acidiﬁcation during cheese man-
ufacture with the starter added together
with B. lactis Bb-12 [89].
Incorporation of probiotic cultures in
cheese does not generally aﬀect primary
proteolysis which in many cheeses results
from activity of the coagulant agent (ex-
cept for high cook cheeses) and, to a
lesser extent, of plasmin and subsequently,
residual coagulant and enzymes from the
starter microﬂora [131]. However, changes
in secondary proteolysis and increases in
free amino acid content have often been
reported when probiotics were added to
cheese [11, 61, 89, 104, 105]. Peptides and
amino acids directly contribute to cheese
ﬂavor (such as sweet, bitter or malty) and
can be precursors for the synthesis of other
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ﬂavors or volatile aroma, resulting in oﬀ-
ﬂavors [5, 128].
During ripening, lipolysis also plays
an important role in the development of
cheese characteristics. The addition of pro-
biotic cultures does not seem to aﬀect the
free fatty acid proﬁle of cheese, likely due
to a higher lipolytic activity of starters
and some NSLAB compared with probi-
otic cultures [28, 61, 63].
Most cheeses containing probiotic lac-
tobacilli and biﬁdobacteria have high
acetic acid content due to heterofermenta-
tion [28,31,61,63,89,104,105]. Biﬁdobac-
teria produce mainly acetic and lactic acid,
in a molar ratio 2:3, from lactose fermen-
tation via the fructose-6-phosphate shunt
pathway. Some lactobacilli can also pro-
duce acetic acid, but to a lesser extent com-
pared with biﬁdobacteria [36]. Acetic acid
contributes to the typical ﬂavor of diﬀerent
cheeses, but excessive concentrations can
also result in oﬀ-ﬂavors [53, 120].
Lactose maldigestion can be alleviated
by β-galactosidase activities of biﬁdobac-
teria [67]. A complete lactose hydroly-
sis was observed in Crescenza, Canes-
trato Pugliese and Cheddar-like cheeses to
which biﬁdobacteria were added, eventu-
ally leading to a small galactose accumula-
tion [28, 31, 61].
As already reported by several au-
thors [15, 118], cheese is a promising food
matrix for probiotics. However, only a few
probiotic cheeses have been successfully
developed for the market compared with
yoghurts or fermented milks. Furthermore,
strain selection and possible process ad-
justments should be carefully evaluated to
maximize probiotic cell viability during
cheese manufacture and storage, as well as
to limit possible changes in organoleptic
properties. Finally, dairy propionibacteria
which have been recently proposed as pro-
biotics [107] could be further researched
for applications as probiotic and ripening
cultures, especially for Swiss-type cheeses.
4. ANTIBIOTIC RESISTANCE
Until recently, safety criteria for food
cultures were mainly based on a long his-
tory of safe use [54, 121]. These crite-
ria were often considered suﬃcient for
use of any strains belonging to a par-
ticular “safe” genus or species in cheese
technology. However, it is now increas-
ingly accepted that strains of almost any
bacterial species can acquire plasmids or
transposons containing antibiotic (AB) re-
sistance genes or virulence factors and
therefore, safety considerations have to
be placed on particular strains. Increasing
concerns over the AB resistance situation
in food-related bacteria are partly due to
excessive use of antibiotics in both human
and veterinary medicine and agriculture [1,
81, 109] and to the high transferability po-
tential of acquired AB resistance genes [3,
110]. During the last decade, the hypothe-
sis that non-pathogenic microorganisms in
fermented food, e.g. LAB in cheese, can
also function as reservoirs for transferable
AB resistance determinants has been ver-
iﬁed [122, 135]. As a consequence, hori-
zontal gene transfer (HGT) of such deter-
minants to other bacteria can occur in the
cheese matrix and surface and once cheese
is consumed, between cheese organisms
and commensal microbiota in the gastroin-
testinal tract. HGT by conjugation between
the cheese isolate Lb. plantarum harboring
the plasmid pLFE1 with the erythromycin
resistance gene erm(B) and E. faecalis was
measured at high frequency in gnotobiotic
rats even without selective pressure [46].
The presence of AB resistance genes in
both isolated LAB from fermented foods,
such as cheese, and LAB of human ori-
gin is the ﬁrst evidence for such AB re-
sistance gene transfer, as recently reviewed
by Ammor et al. [3]. The best docu-
mented examples are tetracycline and ery-
thromycin resistance genes found in ente-
rococci in European cheeses [70, 135]. AB
resistance genes were also characterized in
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cheese LAB isolates belonging to the gen-
era Lactobacillus, Lactococcus and Leu-
conostoc [3]. Furthermore, transferability
of AB resistance genes derived from plas-
mids and transposons of cheese LAB iso-
lates was demonstrated in vitro between
diﬀerent species of LAB by conjugation on
agar plates [109].
A second indication of HGT is the
increasing prevalence of AB-resistant
non-Enterococcus LAB isolates from
cheeses [3,27,50,69,109,136]. Phenotypic
analysis of AB resistance among LAB
was always limited by diﬀerent method-
ological approaches used to determine
AB susceptibility-resistance breakpoints
of dairy strains and biﬁdobacteria. The
use of the micro-dilution method for
determining minimal inhibitory concen-
trations of antibiotics in non-clinical,
non-Enterococcus LAB and biﬁdobacteria
was highly recommended [38, 76]. Re-
sults for phenotypic resistance are then
compared with the breakpoints established
for the species [50]. Now available are
new molecular screening tools based on
microarray hybridization allowing rapid
screening of AB resistance genes [111].
With a microarray targeting ninety dif-
ferent AB resistance determinants mainly
from Gram-positive bacteria, Kastner
et al. [73] showed that among thirty LAB
starter strains used for cheese production,
none contained acquired AB resistance
genes, in contrast to several meat LAB
starters and two probiotic cultures: Lac-
tobacillus reuteri SD 2112 with the
plasmid-encoded tetracycline resistance
gene tet(W) and the lincosamide resistance
gene lnu(A); and Biﬁdobacterium animalis
subsp. lactis DSM 10140 with tet(W).
To conclude, AB resistance screening of
industrial cultures and novel strains should
be done systematically. Strain identiﬁca-
tion by phenotypic and genotypic methods
and the absence of transferable AB resis-
tance genes and virulence factors are im-
portant criteria which will be implemented
in European food legislation [42, 43]. Ac-
cording to criteria set by the European
Food Safety Authority [44], intrinsic AB
resistance or AB resistance due to muta-
tion of chromosomal genes represent ac-
ceptable risks of dissemination by HGT,
but acquired AB resistances are risk factors
for public health.
5. TECHNOLOGICAL
CHALLENGES AND
PROSPECTS FOR INNOVATIVE
TECHNOLOGIES
The incorporation of functional cultures
in cheese must have no deleterious ef-
fects on the cheese manufacturing pro-
cess and product quality. This implies that
metabolic activities (e.g. lactic acid, aroma
and ﬂavor productions) of cultures with
added functionalities must be similar to
those of the original starter culture. On the
other hand, a functional culture should not
be impaired to provide the desired eﬀect.
Technological challenges and possible so-
lutions for application of protective and
probiotic cultures in cheese are discussed
below.
5.1. Challenges related to
bacteriocinogenic cultures
in cheese
As discussed previously, bacteriocino-
genic strains can aﬀect the growth of starter
cultures, and milk and curd acidiﬁcation.
Conversely, good growth of the producer
strains in the presence of the starter cul-
ture is also needed because bacteriocin
production is directly related to cell con-
centration. To overcome this major lim-
itation, bacterial strains for starter cul-
tures must be carefully selected. Bouksaim
et al. [14] highlighted the importance of the
inoculum ratio of bacteriocinogenic strains
and starter cultures for controlled acidi-
ﬁcation and production in Gouda cheese.
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A very small change in the proportion of
mixed culture inoculum from 0.4/1.4% to
0.6/1.4% between the nisinogenic strain
(Lc. diacetylactis UL719) and Flora Dan-
ica starter led to a large increase in num-
bers of UL719 accompanied by changes in
nisin Z activity in cheese, i.e. from non-
detectable to 256 international units (cor-
responding to 6.4 μg pure nisin) per gram
of cheese, although composition of cheeses
was similar to control cheese made with
1.4% Flora Danica only. This study clearly
showed the great challenge of controlling
bacteriocinogenic strain activity in cheese.
The use of bacteriocin-resistant strains has
also been proposed by several authors to
overcome the deleterious eﬀects of bac-
teriocin on acidifying capacity of starter
cultures [8,95]. However, the selection pro-
cess can be diﬃcult, particularly in the case
of cheese with complex microﬂora. Fur-
thermore, other technological parameters
(e.g. bacteriophage resistance of starter and
bacteriocin cultures) are also important for
cheese applications.
Technological properties (e.g. ability to
grow and acidify in milk) and/or safety sta-
tus (e.g. bacteriocinogenic strains carrying
AB resistance and/or belonging to genus or
species which includes pathogenic strains)
of bacteriocinogenic strains can also limit
their applications in cheese. As a possi-
ble solution, the heterologous production
of bacteriocin in GRAS strains with rele-
vant technological properties was success-
fully attempted [16, 115].
Despite extensive research done on
bacteriocins and bacteriocinogenic strains,
few products are commercially avail-
able, reﬂecting the diﬃculties of imple-
mentation of such protective cultures in
cheese manufacturing. Although heterolo-
gous production of bacteriocins has good
potential to facilitate applications of bac-
teriocinogenic cultures in cheese, regula-
tory considerations and general consumer
opposition to use of genetically modiﬁed
organisms in food will likely block this de-
velopment.
5.2. Innovative technologies for
production of cheese cultures
Industrial processes for food culture
production, including cheese cultures and
probiotics, almost exclusively use con-
ventional batch fermentation with sus-
pended cells cultivated separately. Sep-
arately produced cultures are eventually
mixed after production to formulate com-
mercial preparations. For bacterial surface-
ripened cheeses, cheeses after salting are
either inoculated with commercial deﬁned
mixed cultures containing diﬀerent strains
of Brevibacterium linens, Debaromyces
hansenii and/or Geotrichum candidum, or
in some countries are washed with smears
from older cheeses (“old-young” smearing
method) [17].
However, both approaches have disad-
vantages, such as limited biodiversity for
controlled inoculation and contamination
risks by undesirable contaminants for the
“old-young” smearing method. The devel-
opment of technologies enabling a con-
trolled propagation of complex microﬂora
could be very useful for controlling con-
tamination and developing cheese surface
ﬂora, leading to high product quality and
safety.
Cell immobilization has been used to
perform high cell density fermentations
for both cell and metabolite productions
with several advantages over free-cell fer-
mentations, including: high cell densities,
reuse of biocatalysts, improved resistance
to contamination and bacteriophage attack,
enhancement of plasmid stability, preven-
tion from washing-out during continu-
ous cultures, and the physical and chem-
ical protection of cells [78, 79]. Recently,
we developed and validated new contin-
uous fermentation systems with immobi-
lized human fecal microbiota to closely
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model intestinal fermentation and stably
cultivate complex microbiota [24,25]. Sim-
ilar approaches could be used to stabilize
and propagate complex cheese surface mi-
croﬂora, and eventually develop dynamic
fermentor models to study cheese surface
ecosystems.
Current data also suggest that cell im-
mobilization combined with continuous
culture might also be used to eﬃciently
produce, in a one-step process, functional
cultures and probiotic cells with enhanced
tolerance to environmental stresses and im-
proved technological and functional char-
acteristics [78, 79]. Recent studies with
immobilized lactobacilli and continuous
mixed strain cultures have reported signiﬁ-
cant physiological changes, such as a large
increase in cell tolerance to nisin and low
pH, and enhanced acidiﬁcation capacity of
cheese cultures [65, 77].
6. CONCLUSION
Despite a great deal of basic and applied
research carried out on identiﬁcation, char-
acterization and development of bacterio-
cinogenic strains in cheese over the past
thirty years or even more, very few ap-
plications have reached the market. This
situation is largely explained by the diﬃ-
culty of applying bacteriocinogenic strains
in the context of industrial cheese pro-
duction where needs for robust and re-
producible processes are high. Selection
of competitive bacteriocinogenic strains in
cheese environments and suitable starters
with low sensitivity to the bacteriocin is a
prerequisite for successful large-scale ap-
plications. Development of culture rota-
tion to respond to bacteriophage attacks
is also needed. Furthermore, strict pro-
cess control is required to achieve proper
growth of starter, secondary and adjunct
cultures and production of uniform, high
quality and safe cheese. If this can be
achieved, in situ bacteriocin production
could be used both to enhance microbio-
logical safety of cheese and to accelerate
cheese ripening. One of the most promis-
ing applications of protective cultures is
on cheese surfaces where post-processing
contamination is more likely to occur and
no interference with starter cultures is ex-
pected. The selection and development
of complex natural cheese surface mi-
croﬂora with protective properties against
spoilage and pathogenic contaminants is
especially attractive but will require devel-
opment of suitable technologies for con-
trolled propagation of complex cultures.
Furthermore, the development of antifun-
gal cultures with protective eﬀects associ-
ated with minimal metabolism in cheese
is rapidly evolving and similar concepts
relying on synergistic mixtures of non-
protein low-molecular-weight metabolites
could be further developed to target bacte-
rial contaminants.
Cheese is also a very suitable but under-
used carrier for the delivery of probotics,
with speciﬁc advantages compared to fer-
mented milks and yoghurts for maintain-
ing high cell viability and with potential to
enlarge the range of probiotic strains used
in functional dairy products. It is there-
fore expected that new functional cheeses
will be developed on the market, eventu-
ally harboring resident cultures with probi-
otic features not yet characterized and ex-
ploited.
Finally, safety of food cultures will
become increasingly important with the
emergence and dissemination of AB resis-
tance genes. In the near future cheese and
probiotic cultures, like any other food cul-
tures, will have to fulﬁll strict testing to
guarantee the absence of acquired AB re-
sistance genes with transfer potential.
REFERENCES
[1] Aarestrup F.M., Veterinary drug usage
and antimicrobial resistance in bacteria
of animal origin, Bas. Clin. Pharmacol.
Toxicol. 96 (2005) 271–281.
438 F. Grattepanche et al.
[2] Abraham S., Cachon R., Colas B., Feron
G., De Coninck J., Eh and pH gradients in
Camembert cheese during ripening: mea-
surements using microelectrodes and corre-
lations with texture, Int. Dairy J. 17 (2007)
954–960.
[3] Ammor M.S., Florez A.B, Mayo B.,
Antibiotic resistance in non-enterococcal
lactic acid bacteria and biﬁdobacteria, Food
Microbiol. 24 (2007) 559–570.
[4] Anastasiou R., Georgalaki M.,
Manolopoulou E., Kandarakis I., De Vuyst
L., Tsakalidou E., The performance of
Streptococcus macedonicus ACA-DC 198
as starter culture in Kasseri cheese produc-
tion, Int. Dairy J. 17 (2007) 208–217.
[5] Ardö Y., Flavour formation by amino acid
catabolism, Biotechnol. Adv. 24 (2006)
238–242.
[6] Bachmann H.P., Bütikofer U., Isolini D.,
Swiss-type cheese, in: Roginski H. (Ed.),
Encyclopedia of Dairy Science, Elsevier,
Oxford, UK, 2004, pp. 363–371.
[7] Benech R.O., Kheadr E.E., Lacroix C.,
Fliss I., Impact of nisin producing cul-
ture and liposome-encapsulated nisin on
ripening of Lactobacillus added-Cheddar
cheese, J. Dairy Sci. 86 (2003) 1895–1909.
[8] Benech R.O., Kheadr E.E., Laridi R.,
Lacroix C., Fliss I., Inhibition of Listeria
innocua in Cheddar cheese by addition of
nisin Z in liposomes or by in situ production
in mixed culture, Appl. Environ. Microbiol.
68 (2002) 3683–3690.
[9] Beresford T.P., Fitzsimons N.A., Brennan
N.L., Cogan T.M., Recent advances in
cheese microbiology, Int. Dairy J. 11 (2001)
259–274.
[10] Bergamini C.V., Hynes E.R., Quiberoni A.,
Suárez V.B., Zalazar C.A., Probiotic bacte-
ria as adjunct starters: inﬂuence of the ad-
dition methodology on their survival in a
semi-hard Argentinean cheese, Food Res.
Int. 38 (2005) 597–604.
[11] Bergamini C.V., Hynes E.R., Zalazar C.A.,
Inﬂuence of probiotic bacteria on the pro-
teolysis proﬁle of a semi-hard cheese, Int.
Dairy J. 16 (2006) 856–866.
[12] Bernbom N., Licht T.R., Brogren C.H.,
Jelle B., Johansen A.H., Badiola I.,
Vogensen F.K., Nørrung B., Eﬀect of
Lactococcus lactis on composition of
intestinal microbiota: role of nisin, Appl.
Environ. Microbiol. 72 (2006) 239–244.
[13] Bockelmann W., Willems K.P., Neve H.,
Heller K.H., Cultures for the ripening of
smear cheeses, Int. Dairy J. 15 (2005) 719–
732.
[14] Bouksaim M., Lacroix C., Audet P., Simard
R.E., Eﬀects of mixed starter composition
on nisin Z production by Lactococcus lac-
tis subsp lactis biovar. diacetylactis UL 719
during production and ripening of Gouda
cheese, Int. J. Food Microbiol. 59 (2000)
141–156.
[15] Boylston T.D., Vinderola C.G., Ghoddusi
H.B., Reinheimer J.A, Incorporation of biﬁ-
dobacteria into cheeses: challenges and re-
wards, Int. Dairy J. 14 (2004) 375–387.
[16] Brede D.A., Faye T., Stierli M.P., Dasen G.,
Theiler A., Nes I.F., Meile L., Holo H.,
Heterologous production of antimicrobial
peptides in Propionibacterium freudenre-
ichii, Appl. Environ. Microbiol. 71 (2005)
8077–8084.
[17] Brennan T.M., Cogan M., Loessner M.,
Scherer S., Bacterial surface-ripened
cheeses, in: Fox P.F., Mc Sweeney P.L.H,
Cogan T.M., Guinee T.P. (Eds.), Cheese:
Major Cheese Groups, Elsevier, Oxford,
UK, 2004, pp. 199–225.
[18] Brul S., Coote P., Preservative agents in
foods – Mode of action and microbial resis-
tance mechanisms, Int. J. Food Microbiol.
50 (1999) 1–17.
[19] Buriti F.C.A., da Rocha J.S., Saad S.M.I.,
Incorporation of Lactobacillus acidophilus
in Minas fresh cheese and its implication
for textural and sensorial properties during
storage, Int. Dairy J. 15 (2005) 1279–1288.
[20] Champagne C., Gardner N., Roy D.,
Challenges in the addition of probiotic cul-
tures to foods, Crit. Rev. Food Sci. Nutr. 45
(2005) 61–84.
[21] Cheigh C.I., Pyun Y.R., Nisin biosynthe-
sis and its properties, Biotechnol. Lett. 27
(2005) 1641–1648.
[22] Chipley J.R., Sodium benzoate and ben-
zoic acid, in: Davidson P.M., Branen A.L.
(Eds.), Antimicrobials in Foods, Marcel
Dekker Inc., New York., USA, 1993, pp.
46.
[23] Choisy C., Desmazeaud M., Gripon J.C.,
Lamberet G., Lenoir J., La biochimie de
l’aﬃnage, in: Eck A., Gillis J.C. (Eds.),
Le Fromage, Lavoisier, Paris, 1997, pp. 86–
161.
Protective and probiotic cultures for cheese 439
[24] Cinquin C., Le Blay G., Fliss I., Lacroix C.,
Immobilization of infant fecal microbiota
and utilization in an in vitro colonic fermen-
tation model, Microb. Ecol. 48 (2004) 128–
138.
[25] Cinquin C., Le Blay G., Fliss I., Lacroix C.,
New three-stage in vitro model for infant
colonic fermentation with immobilized fe-
cal microbiota, FEMS Microbiol. Ecol. 57
(2006) 324–336.
[26] Cleveland J., Montville T.J., Nes I.F.,
Chikindas M.L., Bacteriocins: safe, natural
antimicrobials for food preservation, Int. J.
Food Microbiol. 71 (2001) 1–20.
[27] Coppola R., Succi M., Tremante P., Reale
A., Salzano G., Sorrentino Z., Antibiotic
susceptibility of Lactobacillus rhamnosus
strains isolated from Parmegiano Reggiona
cheese, Lait 85 (2005) 193–204.
[28] Corbo M.R., Albenzio M., De Angelis M.,
Sevi A., Gobbetti M., Microbiological
and biochemical properties of Canestrato
Pugliese hard cheese supplemented with bi-
ﬁdobacteria, J. Dairy Sci. 84 (2001) 551–
561.
[29] Corsetti A., Gobbetti M., Rossi J., Damiani
P., Antimould activity of sourdough lactic
acid bacteria: identiﬁcation of a mixture of
organic acids produced by Lactobacillus
sanfrancisco CB1, Appl. Microbiol.
Biotechnol. 50 (1998) 253–256.
[30] Cronin T., Ziino M., Condurso C.,
McSweeney P.L.H., Mills S., Ross R.P.,
Stanton C., A survey of the microbial
and chemical composition of seven semi-
ripened Provola dei Nebrodi Sicilian
cheeses, J. Appl. Microbiol. 103 (2007)
1128–1139.
[31] Daigle A., Roy D., Bélanger G., Vuillemard
J.C., Production of probiotic cheese
(Cheddar-like cheese) using enriched
cream fermented by Biﬁdobacterium infan-
tis, J. Dairy Sci. 82 (1999) 1081–1091.
[32] Dave R.I., Shah N.P., Eﬀect of cysteine on
the viability of yoghurt and probiotic bac-
teria in yoghurts made with commercial
starter cultures, Int. Dairy J. 7 (1997) 537–
545.
[33] Dave R.I., Shah N.P., Ingredient supple-
mentation eﬀects on viability of probiotic
bacteria in yoghurt, J. Dairy Sci. 81 (1998)
2804–2816.
[34] Davidson P.M., Doan C.H., Natamycin,
in: Davidson P.M., Branen A.L. (Eds.),
Antimicrobials in Foods, Marcel Dekker
Inc., New York, USA, 1993, pp. 395.
[35] Delbès C., Ali-Mandjee L., Montel M.C.,
Monitoring bacterial communities in raw
milk and cheese by culture-dependent and
-independent 16S rRNA gene-based anal-
yses, Appl. Environ. Microbiol. 73 (2007)
1882–1891.
[36] Desai A.R., Powell I.B., Shah N.P., Survival
and activity of probiotic lactobacilli in skim
milk containing prebiotics, J. Food Sci. 69
(2004) 57–60.
[37] Dinakar P., Mistry V.V., Growth and viabil-
ity of Biﬁdobacterium biﬁdum in Cheddar
cheese, J. Dairy Sci. 77 (1994) 2854–2864.
[38] Domig K.J., Mayrhofer S., Zitz U., Mair
C., Peterson A., Amtmann E., Mayer
H.K., Kneifel W., Antibiotic susceptibility
testing of Biﬁdobacterium thermophilum
and Biﬁdobacterium pseudolongum strains:
broth microdilution vs. agar disc diﬀusion
assay, Int. J. Food Microbiol. 120 (2007)
191–195.
[39] Drider J., Fimland G., Héchard Y.,
McMullen L.M., Prévost H., The con-
tinuing story of class IIa bacteriocins,
Microbiol. Mol. Biol. Rev. 70 (2006)
564–582.
[40] Ennahar S., Aoude-Werner D., Sorokine O.,
van Dorsselaer A., Bringel F., Hubert J.C.,
Hasselmann C., Production of pediocin
AcH by Lactobacillus plantarum WHE92
isolated from cheese, Appl. Environ.
Microbiol. 62 (1996) 4381–4387.
[41] Ennahar S., Assobhel O., Hasselmann C.,
Inhibition of Listeria monocytogenes in a
smear-surface soft cheese by Lb. plantarum
WHE92, a pediocin AcH producer, J. Food
Prot. 61 (1998) 186–191.
[42] European Commission (2002), Opinion
of the Scientiﬁc Committee on Animal
Nutrition on the criteria for assessing the
safety of micro-organisms resistant to
antibiotics of human clinical and veterinary
importance, European Commission, Health
and Consumer Protection Directorate
General, Directorate C, Scientiﬁc Opinions,
Brussels, Belgium.
[43] European Food Safety Authority (2004),
EFSA Scientiﬁc Colloquium Summary
Report, QPS: qualiﬁed presumption of
safety of microorganisms in food and feed,
European Food Safety Authority, Brussels,
Belgium.
440 F. Grattepanche et al.
[44] European Food Safety Authority (2005),
Updating of the criteria used in the assess-
ment of bacteria for resistance to antibi-
otics of human or veterinary importance,
Question No. EFSA-Q2004-079 adopted
on May 2005, The EFSA Journal 223,
pp. 1–12.
[45] FAO/WHO, Guidelines for the evalua-
tion of probiotics in food, Food and
Agricultural Organization of the United
Nations and World Health Organization,
Working Group Report, London, Ontario,
Canada, 2002.
[46] Feld L., Schjorring S., Hammer K., Licht
T.R., Danielsen M., Krogﬂet K., Wilcks A.,
Selective pressure aﬀects transfer and es-
tablishment of a Lactobacillus plantarum
resistance plasmid in the gastrointestinal
environment, J. Antimicrob. Chemother. 61
(2008) 845–852.
[47] Filtenborg O.J., Frisvad C., Thrane U.,
Moulds in food spoilage, Int. J. Food
Microbiol. 33 (1996) 85–102.
[48] Fleet G.H., Yeasts in dairy products, J.
Appl. Bacteriol. 68 (1990) 199–211.
[49] Flórez A.B., Mayo B., Microbial diver-
sity and succession during the manufacture
and ripening of traditional, Spanish, blue-
veined Cabrales cheese, as determined by
PCR-DGGE, Int. J. Food Microbiol. 110
(2006) 165–171.
[50] Flórez A.B., Delgado S., Mayo B.,
Antimicrobial susceptibility of lactic acid
bacteria isolated from a cheese envi-
ronment, Can. J. Microbiol. 51 (2005)
51–58.
[51] Fontaine L., Hols P., The inhibitory spec-
trum of thermophilin 9 from Streptococcus
thermophilus LMD-9 depends on the pro-
duction of multiple peptides and the activity
of BlpGSt, a thiol-disulﬁde oxidase, Appl.
Environ. Microbiol. 74 (2008) 1102–1110.
[52] Foulquié Moreno M.R., Sarantinopoulos P.,
Tsakalidou E., De Vuyst L., The role and
application of enterococci in food and
health, Int. J. Food Microbiol. 106 (2006)
1–24.
[53] Fox P.F., Wallace J.M., Formation of ﬂa-
vor compounds in cheese, Adv. Appl.
Microbiol. 45 (1997) 17–85.
[54] Franz C.M.A.P., Stiles M.E., Schleifer
K.H., Holzapfel W.H., Enterococci in foods
– a conundrum for food safety, Int. J. Food.
Microbiol. 88 (2003) 105–122.
[55] Gálvez A., Abriouel H., López R.L., Omar
N.B., Bacteriocin-based strategies for food
preservation, Int. J. Food Microbiol. 120
(2007) 51–70.
[56] Garde S., Avila M., Fernández-García E.,
Medina M., Nuñez M., Volatile com-
pounds and aroma of Hispanico cheese
manufactured using lacticin 481-producing
Lactococcus lactis ssp. lactis INIA 639 as
an adjunct culture, Int. Dairy J. 17 (2007)
717–726.
[57] Garde S., Avila M., Gaya P., Medina M.,
Nuñez M., Proteolysis of Hispánico cheese
manufactured using lacticin 481-producing
Lactococcus lactis ssp. lactis INIA 639, J.
Dairy Sci. 89 (2006) 840–849.
[58] Gardiner G., Stanton C., Lynch P.B.,
Collins J.K., Fitzgerald G., Ross R.P.,
Evaluation of Cheddar cheese as a food
carrier for delivery of a probiotic strain to
the gastrointestinal tract, J. Dairy Sci. 82
(1999) 1379–1387.
[59] Georgalaki M.D., Van den Berghe E.,
Kritikos D., Devreese B., Van Beeumen
J., Kalantzopoulos G., De Vuyst L.,
Tsakalidou E., Macedocin, a food-grade
lantibiotic produced by Streptococcus
macedonicus ACA-DC 198, Appl. Environ.
Microbiol. 68 (2002) 5891–5903.
[60] Giraﬀa G., Functionality of enterococci in
dairy products, Int. J. Food Microbiol. 88
(2003) 215–222.
[61] Gobbetti M., Corsetti A., Smacchi E.,
Zocchetti A., De Angelis M., Production of
Crescenza cheese by incorporation of biﬁ-
dobacteria, J. Dairy Sci. 81 (1998) 37–47.
[62] Gobbetti M., De Angelis M., Di Cagno R.,
Minervini F., Limitone A., Cell-cell com-
munication in food related bacteria, Int. J.
Food Microbiol. 120 (2007) 34–45.
[63] Gomes A.M.P., Malcata F.X., Development
of probiotic cheese manufactured from goat
milk: response surface analysis via tech-
nological manipulation, J. Dairy Sci. 81
(1998) 1492–1507.
[64] Goulet V., de Valk H, Pierre O., Stainer
F., Rocourt J., Vaillant V., Jacquet C.,
Desenclos J.C., Eﬀect of prevention mea-
sures on incidence of human listeriosis,
France 1987–1997, Emerg. Inf. Dis. 7
(2001) 983–898.
[65] Grattepanche F., Audet P., Lacroix C.,
Enhancement of functional characteristics
of mixed lactic culture producing nisin Z
Protective and probiotic cultures for cheese 441
and exopolysaccharides during continuous
prefermentation of milk with immobilized
cells, J. Dairy Sci. 90 (2007) 5361–5373.
[66] Guinane C.M., Cotter P.D., Hill C., Ross
R.P., Microbial solutions to microbial prob-
lems; lactococcal bacteriocins for the con-
trol of undesirable biota in food, J. Appl.
Microbiol. 98 (2005) 1316–1325.
[67] He T., Priebe M.G., Zhong Y., Huang
C., Harmsen H.J.M., Raang G.C., Antoine
J.M., Welling G.W., Vonk R.J., Eﬀects
of yogurt and biﬁdobacteria supplementa-
tion on the colonic microbiota in lactose-
intolerant subjects, J. Appl. Microbiol. 104
(2008) 595–604.
[68] Holzapfel W.H., Haberer P., Geisen R.,
Björkroth J., Schillinger U., Taxonomy and
important features of probiotic microorgan-
isms in food and nutrition, Am. J. Clin.
Nutr. 73 (2001) 365–373.
[69] Hummel A.S., Hertel C., Holzapfel W.H.,
Franz C.M.A., Antibiotic resistances of
starter and probiotic strains of lactic acid
bacteria, Appl. Environ. Microbiol. 73
(2007) 730–739.
[70] Huys G., D’Haene K., Collard J.M.,
Swings J., Prevalence and molecular char-
acterization of tetracycline resistance in
Enterococcus isolates from food, Appl.
Environ. Microbiol. 70 (2004) 1555–1562.
[71] Jan G., Rouault A., Maubois J.L., Acid
stress susceptibility and acid adaptation
of Propionibacterium freudenreichii subsp.
sherrmanii, Lait 80 (2000) 325–336.
[72] Jayamanne V.S., Adams M.R., Determina-
tion of survival, identity and stress resis-
tance of probiotic biﬁdobacteria in bio-
yoghurts, Lett. Appl. Microbiol. 42 (2006)
189–194.
[73] Kastner S., Perreten V., Bleuler H.,
Hugenschmidt G., Lacroix C., Meile L.,
Antibiotic susceptibility patterns and
resistance genes of starter cultures and
probiotic bacteria used in food, Syst. Appl.
Microbiol. 29 (2006) 145–155.
[74] Kirkup B.C., Bacteriocins as oral and gas-
trointestinal antibiotics: theoretical consid-
erations, applied research, and practical ap-
plications, Curr. Med. Chem. 27 (2006)
3335–3350.
[75] Klaenhammer T.R., Genetics of bacteri-
ocins produced by lactic acid bacteria,
FEMS Microbiol. Rev. 12 (1993) 39–85.
[76] Klare I., Konstabel C., Werner G., Huys
G., Vankerckhoven V., Kahlmeter G.,
Hildebrandt B., Müller-Bertling S., Witt
W., Goossens H., Antimicrobial suscepti-
bilities of Lactococcus human isolates and
cultures intended for probiotic or nutri-
tional use, J. Antimicrob. Chemother. 59
(2007) 900–912.
[77] Koch S.R., Eﬀects of fermentation condi-
tions on viability, physiological and tech-
nological characteristics of autolytic dried
direct vat set lactic starter cultures, Ph.D.
thesis, 2006, ETH, Zürich, Switzerland.
[78] Lacroix C., Grattepanche F., Doleyres Y.,
Bergmaier D., Immobilized cell technolo-
gies for the dairy industry, in: Nevidovic
V., Willaert R. (Eds.), Applications
of Cell Immobilization Biotechnology,
Series: Focus on Biotechnology, Vol. 8B,
Springer-Verlag, Berlin, Germany, pp.
295–319.
[79] Lacroix C., Yildirim S., Fermentation tech-
nologies for the production of probiotics
with high viability and functionality, Curr.
Opin. Biotechnol. 18 (2007) 176–183.
[80] Lazzi C., Rossetti L., Zago M., Neviani
E., Giraﬀa G., Evaluation of bacterial
communities belonging to natural whey
starters for Grana Padano cheese by length
heterogeneity-PCR, J. Appl. Microbiol. 96
(2004) 481–490.
[81] Levy S.B., Marshall B., Antibacterial resis-
tance worldwide: causes, challenges and re-
sponses, Nature Med. 10 (2004) 122–129.
[82] Little C.L., Rhoades J.R., Sagoo S.K.,
Harris J., Greenwood M., Mithani V., Grant
K., McLauchlin J., Microbiological qual-
ity of retail cheeses from raw, thermized
or pasteurized milk in the UK, Food
Microbiol. 25 (2008) 304–312.
[83] Loessner M., Guenther S., Steﬀan S.,
Scherer S., A pediocin-producing Lacto-
bacillus plantarum strain inhibits Listeria
monocytogenes in a multispecies cheese
surface microbial ripening consortium,
Appl. Environ. Microbiol. 69 (2003) 1854–
1857.
[84] Magnusson J., Schnürer J., Lactobacillus
coryniformis subsp. coryniformis strain
Si3 produces a broad-spectrum proteina-
ceous antifungal compound, Appl. Environ.
Microbiol. 67 (2001) 1–5.
[85] Maoz A., Mayr R., Scherer S., Temporal
stability and biodiversity of two complex
442 F. Grattepanche et al.
antilisterial cheese-ripening microbial con-
sortia, Appl. Environ. Microbiol. 69 (2003)
4012–4018.
[86] Martínez-Cuesta M.C., Peláez C., Juárez
M., Requena T., Autolysis of Lactococcus
lactis ssp. lactis and Lactobacillus casei
ssp. casei. Cell lysis induced by a crude
bacteriocin, Int. J. Food Microbiol. 38
(1997) 125–131.
[87] Martínez-Cuesta M.C., Requena T.,
Peláez C., Use of a bacteriocin-producing
transconjugant as starter in acceleration of
cheese ripening, Int. J. Food Microbiol. 70
(2001) 79–88.
[88] Martínez-Cuesta M.C., Requena T., Peláez
C., Cell membrane damage induced by
lacticin 3147 enhances aldehyde formation
in Lactococcus lactis IFLP730, Int. J. Food
Microbiol. 109 (2006) 1989–204.
[89] Mc Brearty S., Ross R.P., Fitzgerald G.F.,
Collins J.K., Wallace J.M., Stanton C.,
Inﬂuence of two commercially available
biﬁdobacteria cultures on Cheddar cheese
quality, Int. Dairy J. 11 (2001) 599–610.
[90] Meile L., Le Blay G., Thierry A., Safety
assessment of dairy microorganisms:
Propionibacterium and Biﬁdobacterium,
Int. J. Food Microbiol. 126 (2008) 316–
320.
[91] Miescher Schwenninger S., Meile L.,
A mixed culture of Propionibacterium
jensenii and Lactobacillus paracasei subsp.
paracasei inhibits food spoilage yeasts,
Syst. Appl. Microbiol. 27 (2004) 229–237.
[92] Miescher Schwenninger S., Von Ah U.,
Niederer B., Teuber M., Meile L., Detection
of antifungal properties in Lactobacillus
paracasei subsp. paracasei SM20, SM29,
and SM63 and molecular typing of the
strains, J. Food Prot. 68 (2005) 111–119.
[93] Millet L., Didienne R., Tessier L., Montel
M.C., Control of Listeria monocytogenes in
raw milk cheeses, Int. J. Food Microbiol.
108 (2006) 105–114.
[94] Morency H., Mota-Meira M., LaPointe G.,
Lacroix C., Lavoie M.C., Comparison of
the activity spectra against pathogens of
bacterial strains producing a mutacin or a
lantibiotic, Can. J. Microbiol. 47 (2001)
322–331.
[95] Morgan S.M., O’Sullivan L., Ross R.P., Hill
C., The design of a three strain starter sys-
tem for Cheddar cheese manufacture ex-
ploiting bacteriocin-induced starter lysis,
Int. Dairy J. 12 (2002) 985–993.
[96] Mounier J., Monnet C., Vallaeys T., Arditi
R., Sarthou A.S., Helias A., Irlinger F.,
Microbial interactions within a cheese
microbial community, Appl. Environ.
Microbiol. 74 (2008) 172–181.
[97] Muñoz A., Ananou S., Gálvez A.,
Martínez-Bueno M., Rodríguez A.,
Maqueda M., Valdivia E., Inhibition of
Staphylococcus aureus in dairy products
by enterocin AS-48 produced in situ and
ex situ: bactericidal synergism with heat,
Int. Dairy J. 17 (2007) 760–769.
[98] Naghmouchi K., Kheadr E., Lacroix C.,
Fliss I., Class I/Class IIa bacteriocin cross-
resistance phenomenon in Listeria monocy-
togenes, Food Microbiol. 24 (2007) 718–
727.
[99] Nes I.F., Diep D.B., Holo H.,
Bacteriocin diversity in Streptococcus
and Enterococcus, J. Bacteriol. 189 (2007)
1189–1198.
[100] Niku-Paavola M.L., Laitila A., Mattila-
Sandholm T., Haikara A., New types
of antimicrobial compounds produced
by Lactobacillus plantarum, J. Appl.
Microbiol. 86 (1999) 29–35.
[101] Nuñez M., Rodríguez J.L., García E., Gaya
P., Medina M., Inhibition of Listeria mono-
cytogenes by enterocin 4 during the manu-
facture and ripening of Manchego cheese,
J. Appl. Microbiol. 83 (1997) 617–677.
[102] O’Sullivan L., O’Connor E.B., Ross R.P.,
Hill C., Evaluation of live-culture-
producing lacticin 3147 as a treatment for
the control of Listeria monocytogenes on
the surface of smear-ripened cheese, J.
Appl. Microbiol. 100 (2006) 135–143.
[103] Ogier J.C., Lafarge V., Girard V., Rault
A., Maladen V., Gruss A., Leveau J.Y.,
Delacroix-Buchet A., Molecular ﬁnger-
printing of dairy microbial ecosystems by
use of temporal temperature and denaturing
gradient gel electrophoresis, Appl. Environ.
Microbiol. 70 (2004) 5628–5643.
[104] Ong L., Henriksson A., Shah N.P.,
Development of probiotic Cheddar cheese
containing Lactobacillus acidophilus, Lb.
casei, Lb. paracasei and Biﬁdobacterium
spp. and the inﬂuence of these bacteria
on proteolytic patterns and production
of organic acids, Int. Dairy J. 16 (2006)
446–456.
[105] Ong L., Henriksson A., Shah N.P.,
Proteolytic pattern and organic acid
proﬁles of probiotic Cheddar cheese
Protective and probiotic cultures for cheese 443
as inﬂuenced by probiotic strains of
Lactobacillus acidophilus, Lb. paracasei,
Lb. casei or Biﬁdobacterium spp., Int.
Dairy J. 17 (2007) 67–78.
[106] Ouwehand A.C., The probiotic poten-
tial of propionibacteria, in: Salminen S.,
von Wright A., Ouwehand A. (Eds.),
Lactic Acid Bacteria: Microbiology and
Functional Aspects, Marcel Dekker Inc.,
New-York, USA, 2004, pp. 159–174.
[107] Ouwehand A.C., Salminen S., Isolauri E.,
Probiotics: an overview of beneﬁcial ef-
fects, Antonie van Leeuwenhoek 82 (2002)
279–289.
[108] Peláez C., Requena T., Exploiting the po-
tential of bacteria in the cheese ecosystem,
Int. Dairy J. 15 (2005) 831–844.
[109] Perreten V., Resistance in the food
chain and in bacteria from animals: rel-
evance to human infections, in: White
D.G., Alekshun N.V., McDermott P.F.
(Eds.), Frontiers in Antibiotic Resistance:
A Tribute to Stuart B. Levy, ASM,
Washington DC, USA, 2005, pp. 446–464.
[110] Perreten V., Schwarz F., Cresta L., Boeglin
M., Dasen G., Teuber M., Antibiotic resis-
tance spread in food, Nature 389 (1997)
801–802.
[111] Perreten V., Vorlet-Fawer L., Slickers P.,
Ehricht R., Kuhnert P., Frey J., Microarray-
based detection of 90 antibiotic resistance
genes of Gram-positive bacteria, J. Clin.
Microbiol. 43 (2005) 2291–2302.
[112] Phillips M., Kailasapathy K., Tran L.,
Viability of commercial probiotic cul-
tures (L. acidophilus, Biﬁdobacterium sp.,
L. paracasei and L. rhamnosus) in Cheddar
cheese, Int. J. Food Microbiol. 108 (2006)
276–280.
[113] Rademaker J.L.W., Peinhopf M., Rijnen L.,
Bockelmann W., Noordman W.H., The
surface microﬂora dynamics of bacterial
smear-ripened Tilsit cheese determined by
T-RFLP DNA population ﬁngerprint analy-
sis, Int. Dairy J. 15 (2005) 785–794.
[114] Randazzo C.L., Torriani S., Akkermans
A.D.L., de Vos W.M., Vaughan E.E.,
Diversity, dynamics, and activity of bacte-
rial communities during production of an
artisanal sicilian cheese as evaluated by 16S
rRNA analysis, Appl. Environ. Microbiol.
68 (2002) 1882–1892.
[115] Rodríguez J.M., Martínez M.I., Horn N.,
Dodd H.M., Heterologous production of
bacteriocins by lactic acid bacteria, Int. J.
Food Microbiol. 880 (2003) 101–116.
[116] Rollema H.S., Kuipers O.P., Both P., de Vos
W.M., Siezen R.J., Improvement of solubil-
ity and stability of the antimicrobial pep-
tide nisin by protein engineering, Appl.
Environ. Microbiol. 61 (1995) 2873–2878.
[117] Ross P.R., Stanton C., Hill C., Fitzgerald
G.F., Coﬀey A., Novel cultures for cheese
improvement, Trends Food Sci. Technol. 11
(2000) 96–104.
[118] Roy D., Technological aspects related to the
use of biﬁdobacteria in dairy products, Lait
85 (2005) 39–56.
[119] Ryan M.P., Rea M.C., Hill C., Ross R.P., An
application in cheddar cheese manufacture
for a strain of Lactococcus lactis producing
a novel broad-spectrum bacteriocin, lacticin
3147, Appl. Environ. Microbiol. 62 (1996)
612–619.
[120] Rychlik M., Bosset J.O., Flavour and
oﬀ-ﬂavour compounds of Swiss Gruyère
cheese. Identiﬁcation of key odorants by
quantitative instrumental and sensory stud-
ies, Int. Dairy J. 11 (2001) 903–910.
[121] Salminen S., von Wright A., Morelli L.,
Marteau P., Brassart D., de Vos W.M.,
Fondén R., Saxelin M., Collins K.,
Mogensen G., Birkeland S.E., Mattila-
Sandholm T., Demonstration of safety
of probiotics – a review, Int. J. Food
Microbiol. 44 (1998) 93–106.
[122] Salyers A.A., Gupta A., Wang Y., Human
intestinal bacteria as reservoirs for antibi-
otic resistance genes, Trends Microbiol. 12
(2004) 412–416.
[123] Sanders M.E., Walker D.C., Walker
K.M., Aoyama K., Klaenhammer T.R.,
Performance of commercial cultures in
ﬂuid milk applications, J. Dairy Sci. 79
(1996) 943–955.
[124] Saubusse M., Millet L., Delbès C., Callon
C., Montel M.C., Application of Single
Strand Conformation Polymorphism-PCR
method for distinguishing cheese bacterial
communities that inhibit Listeria monocy-
togenes, Int. J. Food Microbiol. 116 (2007)
126–135.
[125] Schnürer J., Magnusson J., Antifungal lac-
tic acid bacteria as biopreservatives, Trends
Food Sci. Technol. 16 (2005) 70–78.
[126] Shah N.P., Lankaputhra W.E.V., Britz M.L.,
Kyle W.S.A., Survival of Lactobacillus
acidophilus and Biﬁdobacterium biﬁdum
444 F. Grattepanche et al.
in commercial yoghurt during refrigerated
storage, Int. Dairy J. 5 (1995) 515–521.
[127] Sjögren, J., Magnusson J., Broberg A.,
Schnürer J., Kenne L., Antifungal
3-hydroxy fatty acids from Lactobacillus
plantarum MiLAB 14, Appl. Environ.
Microbiol. 69 (2003) 7554–7557.
[128] Smit G., Smit B.A., Engels W.J.M., Flavour
formation by lactic acid bacteria and bio-
chemical ﬂavour proﬁling of cheese prod-
ucts, FEMS Microbiol. Rev. 29 (2005) 591–
610.
[129] Smits G.J., Brul S., Stress tolerance in
fungi – to kill a spoilage yeast, Curr. Opin.
Biotechnol. 16 (2005) 225–230.
[130] Sobrino-López A., Martín-Belloso O.,
Use of nisin and other bacteriocins for
preservation of dairy products, Int. Dairy J.
18 (2008) 329–343.
[131] Sousa M.J., Ardö Y., McSweeney P.L.H.,
Advances in the study of proteolysis dur-
ing cheese ripening, Int. Dairy J. 11 (2001)
327–345.
[132] Ström K., Sjögren J., Broberg A., Schnürer
J., Lactobacillus plantarum MiLAB 393
produces the antifungal cyclic dipep-
tides cyclo(L-Phe-L-Pro) and cyclo(L-Phe-
trans-4-OH-L-Pro) and 3-phenyllactic acid,
Appl. Environ. Microbiol. 68 (2002) 4322–
4327.
[133] Suomalainen T.H., Mäyra-Mäkinen A.M.,
Propionic acid bacteria as protective cul-
tures in fermented milks and breads, Lait 79
(1999) 165–174.
[134] Talwalkar A., Kailasapathy K., The role of
oxygen in the viability of probiotic bac-
teria with reference to L. acidophilus and
Biﬁdobacterium spp., Curr. Issues Intest.
Microbiol. 5 (2004) 1–8.
[135] Teuber M., Meile L., Schwarz F., Acquired
antibiotic resistance in lactic acid bacteria
from food, Antonie van Leeuwenhoek 76
(1999) 115–137.
[136] Tosi L., Berruti G., Danielsen M., Wind
A., Huys G., Morelli L., Susceptibility
of Streptococcus thermophilus to antibi-
otics, Antonie Van Leeuwenhoek 92 (2007)
21–28.
[137] Tsakalidou E., Zoidou E., Pot B.,
Wassill L., Ludwig W., Devriese L.A.,
Kalantzopoulos G., Schleifer K.H.,
Kersters K., Identiﬁcation of streptococci
from Greek Kasseri cheese and description
of Streptococcus macedonicus sp. nov., Int.
J. Syst. Bacteriol. 48 (1998) 519–527.
[138] Van den Berghe E., Skourtas G., Tsakalidou
E., De Vuyst L., Streptococcus mace-
donicus ACA-DC 198 produces the lan-
tibiotic, macedocin, at temperature and pH
conditions that prevail during cheese man-
ufacture, Int. J. Food Microbiol. 107 (2006)
138–147.
[139] Vinderola C.G., Prosello W., Ghilberto D.,
Reinheimer J.A., Viability of probiotic
(Biﬁdobacterium, Lactobacillus aci-
dophilus and Lactobacillus casei) and
nonprobiotic microﬂora in Argentinian
Fresco cheese, J. Dairy Sci. 83 (2000)
1905–1911.
[140] Yang Z., Suomalainen T., Mäyrä-Mäkinen
A., Huttunen E., Antimicrobial activity of
2-pyrrolidone-5-carboxylic acid produced
by lactic acid bacteria, J. Food Prot. 60
(1997) 786–790.
[141] Yilmaztekin M., Ozer B.H., Atasoy F.,
Survival of Lactobacillus acidophilus LA-5
and Biﬁdobacterium biﬁdum BB-02 in
white brined cheese, Int. J. Food Sci. Nutr.
55 (2004) 53–60.
